全文获取类型
收费全文 | 202838篇 |
免费 | 2233篇 |
国内免费 | 182篇 |
专业分类
耳鼻咽喉 | 1480篇 |
儿科学 | 7185篇 |
妇产科学 | 3485篇 |
基础医学 | 20037篇 |
口腔科学 | 2215篇 |
临床医学 | 14247篇 |
内科学 | 38460篇 |
皮肤病学 | 1215篇 |
神经病学 | 18456篇 |
特种医学 | 9775篇 |
外科学 | 33383篇 |
综合类 | 2442篇 |
一般理论 | 1篇 |
预防医学 | 18862篇 |
眼科学 | 3179篇 |
药学 | 11233篇 |
中国医学 | 678篇 |
肿瘤学 | 18920篇 |
出版年
2023年 | 138篇 |
2022年 | 298篇 |
2021年 | 509篇 |
2020年 | 300篇 |
2019年 | 361篇 |
2018年 | 22311篇 |
2017年 | 17661篇 |
2016年 | 19890篇 |
2015年 | 1361篇 |
2014年 | 1426篇 |
2013年 | 1569篇 |
2012年 | 8169篇 |
2011年 | 22232篇 |
2010年 | 19502篇 |
2009年 | 12111篇 |
2008年 | 20682篇 |
2007年 | 22929篇 |
2006年 | 1807篇 |
2005年 | 3474篇 |
2004年 | 4677篇 |
2003年 | 5642篇 |
2002年 | 3863篇 |
2001年 | 1208篇 |
2000年 | 1383篇 |
1999年 | 1041篇 |
1998年 | 593篇 |
1997年 | 484篇 |
1996年 | 379篇 |
1995年 | 348篇 |
1994年 | 322篇 |
1993年 | 250篇 |
1992年 | 677篇 |
1991年 | 742篇 |
1990年 | 694篇 |
1989年 | 640篇 |
1988年 | 599篇 |
1987年 | 561篇 |
1986年 | 469篇 |
1985年 | 478篇 |
1984年 | 360篇 |
1983年 | 284篇 |
1982年 | 141篇 |
1980年 | 154篇 |
1979年 | 246篇 |
1978年 | 160篇 |
1977年 | 151篇 |
1974年 | 152篇 |
1972年 | 140篇 |
1970年 | 140篇 |
1969年 | 163篇 |
排序方式: 共有10000条查询结果,搜索用时 12 毫秒
51.
Volker Heinemann 《Breast cancer research and treatment》2003,81(1):43-48
Single-agent chemotherapy of metastatic breast cancer is the treatment of choice in patients with slow tumor progression and asymptomatic disease. In this patient group, the choice of drugs is based more on good tolerability than on efficacy. By contrast, symptomatic or rapidly progressing disease requires the use of highly active regimens where more weight is put on reliable antitumor activity. While anthraycline-based combination regimens have set the standard of effective treatment, the addition of docetaxel (and to a lesser extent paclitaxel) has improved tumor response, but failed to induce a consistent prolongation of survival. Based on retrospective analyses, it is hypothesised that the combined use of anthracyclines and taxanes in first-line therapy may be most beneficial in defined subgroups: after adjuvant chemotherapy, in patients with HER-2 gene amplification, possibly also in patients with rapidly progressing visceral disease. 相似文献
52.
53.
54.
Antegrade interlocking nailing of humeral shaft fractures 总被引:5,自引:0,他引:5
George Petsatodes Dimitrios Karataglis Pericles Papadopoulos John Christoforides John Gigis John Pournaras 《Journal of orthopaedic science》2004,9(3):247-252
The results of 39 humeral shaft fractures (37 patients) treated with antegrade locked nailing using a Russell–Taylor nail were reviewed. There were 30 acute fractures, 6 fractures malaligned in a hanging cast or brace, and 3 pathological fractures. Patient age ranged from 26 to 80 years (average, 59.7 years) and average follow-up was 25.7 months (range, 6–48 months). Fracture union was achieved in 92.3% of our cases, while shoulder function was excellent or good in 87.2% of cases. Antegrade locked nailing offers a dependable solution for the treatment of humeral shaft fractures, especially in polytrauma patients and cases of segmental or pathological fractures. Far less satisfactory results were obtained in comminuted fractures of the proximal third in the humerus, especially in osteoporotic patients, and we therefore advocate caution with the use of intramedullary nailing in this type of fracture. Certain technical aspects such as avoiding nailing the fracture in distraction, properly countersinking the tip of the nail, and achieving adequate fixation stability have been found to be of paramount importance to reduce the incidence of delayed union/non-union rate and to obtain better functional results from the shoulder joint. 相似文献
55.
56.
Daniel M. Herron 《Journal of gastrointestinal surgery》2004,8(4):406-407
Conclusion In the year 2003 there is no “one best bariatric operation” for every severely obese patient. The choice of operation must
be tailored to each individual patient’s needs and wishes. For the superobese patient, the patient diagnosed with intestinal
metaplasia of the stomach, and for those patients who do not wish to undergo the severe dietary restrictions imposed by the
RNY-GB, the BPD-DS is a valuable surgical option. 相似文献
57.
58.
Osamu Yokota Kuniaki Tsuchiya Yoshimasa Noguchi Hisamasa Akabane Hideki Ishizu Yukinobu Saito Haruhiko Akiyama 《Neuropathology》2007,27(6):539-550
We report a case of a 68‐year‐old right‐handed man with sporadic amyotrophic lateral sclerosis (ALS) and argyrophilic grain disease (AGD) having a 22‐month duration. His initial symptoms were dysarthria and swallowing difficulty at the age of 67. Subsequently bulbar palsy and pyramidal signs developed. His cognitive functions including face recognition, personality, and behavior were not changed compared with that of before the disease onset. However, magnetic resonance imaging disclosed severe right side‐predominant temporal atrophy. The neurological diagnosis was bulbar type ALS. Pathological examination disclosed histological evidence of ALS, including loss of Betz cells and lower motor neurons, corticospinal tract degeneration, and Bunina bodies. In addition, severe neuronal loss in the bilateral temporal cortex with an anterior gradient was found. Ubiquitin‐positive inclusions were encountered in the spinal anterior horn cells and hippocampal dentate gyrus, while few ubiquitin‐positive inclusions were noted in the affected temporal cortex. The amygdala, especially the basolateral nuclear group, was severely affected by neuronal loss with tissue rarefaction. Moderate neuronal loss was encountered in the parahippocampal gyrus, and to a lesser degree, in the ambient gyrus. Unexpectedly, many argyrophilic grains, coiled bodies, tau‐positive bush‐like astrocytes, pretangles, and ballooned neurons were found in the limbic system and temporal cortex. In the hippocampus, selective tau accumulation with minor neurofibrillary changes was observed in CA2 neurons. The present case suggests that (i) ALS and AGD do rarely coexist, and (ii) when ALS patients have severe temporal atrophy, not only ALS with dementia but also concurrent AGD should be considered in the differential diagnosis. 相似文献
59.
60.
J T Chen Y Kurokawa K Nakayama K Saito K Sakamoto K Fukuda Y Hirai T Hamada I Fujimoto K Yamauchi 《Nippon Sanka Fujinka Gakkai zasshi》1987,39(5):815-822
Bismuth subnitrate (BSN), a bismuth compound medically used for antidiarrheics, was orally administered to see whether it can reduce CDDP nephrotoxicity or not. Thirteen patients aged 19 approximately 60 with ovarian cancer entered this BSN-CDDP trial. A total of thirty three courses of BSN-CDDP treatment was undergone. BSN was administered orally at a dose of 50 mg/kg for five days before CDDP therapy. CDDP was infused for two hours. No vigorous hydration or diuresis was performed. Only 2,000 ml of saline with 20 mEq per liter of KCl was given for post-hydration. The median dose of CDDP was 100 mg/m2. The renal toxicity of BSN-CDDP treatment was minimum. 82% of the courses at the sixth day after the treatment had creatinine clearance levels which were more than 80% of those before the treatment. But twenty-four hour NAG and beta 2-microglobulin excretion were significantly increased. Bone marrow suppression and gastrointestinal disturbance were commonly observed. The results of our study indicate that BSN pretreatment reduces the renal toxicity of CDDP to some extent. 相似文献